Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Deloitte
Farmers Insurance
Baxter
Queensland Health
Johnson and Johnson
Express Scripts
McKinsey
Merck

Generated: July 17, 2018

DrugPatentWatch Database Preview

Biperiden lactate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for biperiden lactate and what is the scope of biperiden lactate patent protection?

Biperiden lactate
is the generic ingredient in one branded drug marketed by Abbvie and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for biperiden lactate.
Summary for biperiden lactate
Synonyms for biperiden lactate
09TD6C5147
1-(5-bicyclo[2.2.1]hept-2-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol; 2-hydroxypropanoic acid
1-Piperidinepropanol, alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenyl-, compd. with 2-hydroxypropanoic acid (1:1)
7085-45-2
AC1L52UN
Akineton Lactate
alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol compd. with lactic acid (1:1)
alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol lactate (salt)
Biperiden lactate (JAN/USP)
Biperiden lactate [USAN:BAN:JAN]
Biperiden lactate [USP:BAN:JAN]
BIPERIDEN; LACTIC ACID
Biperidenlactat
C21H29NO.C3H6O3
CHEMBL1201067
D02247
EINECS 230-388-9
HE025737
Lactic acid, compd. with alpha-5-norbornen-2-yl-alpha-phenyl-1-piperidinepropanol (1:1)
Lactic acid, compound with alpha-bicyclo(2.2.1)hept-5-en-2-yl-alpha-phenylpiperidin-1-propanol (1:1)
LS-87492
SCHEMBL41834
Tasmolin (TN)
UNII-09TD6C5147

US Patents and Regulatory Information for biperiden lactate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie AKINETON biperiden lactate INJECTABLE;INJECTION 012418-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
US Army
Cipla
Deloitte
McKesson
US Department of Justice
Baxter
Moodys
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.